A new study reports that hyperuricemia is an independent predictor of mortality in people with chronic kidney disease. The findings were published online July 13 in the Journal of Clinical Medicine and point to elevated uric acid as a potentially important marker of risk in CKD.
The research adds to ongoing interest in how metabolic and laboratory measures can help identify patients with chronic kidney disease who may face poorer outcomes. In this case, the study suggests that hyperuricemia is linked to mortality even when considered independently, making it more than a simple accompanying finding.
The paper was led by Rasha Babiker, M.B.B.S., Ph.D., according to the report. While the brief summary does not outline the full study design or patient numbers, the central conclusion is clear: higher uric acid levels may have meaningful prognostic value in chronic kidney disease.
For clinicians and researchers, the findings highlight the potential role of uric acid assessment in evaluating risk among CKD patients. The study also raises further questions about whether closer monitoring or targeted management of hyperuricemia could influence long-term outcomes in this population.
